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Selection pressures exerted on Staphylococcus aureus by host factors may lead to the
emergence of mutants better adapted to the evolving conditions at the infection site.
This study was aimed at identifying the changes that occur in S. aureus exposed to the
host defense mechanisms during chronic osteomyelitis and evaluating whether these
changes affect the virulence of the organism. Genome assessment of two S. aureus
isolates collected 13 months apart (HU-85a and HU-85c) from a host with chronic
osteomyelitis was made by whole genome sequencing. Agr functionality was assessed
by qRT-PCR. Isolates were tested in a rat model of osteomyelitis and the bacterial
load (CFU/tibia) and the morphometric osteomyelitic index (OI) were determined. The
ability of the isolates to trigger the release of proinflammatory cytokines was determined
on macrophages in culture. Persistence of S. aureus within the host resulted in an
agrC frameshift mutation that likely led to the observed phenotype. The capacity to
cause bone tissue damage and trigger proinflammatory cytokines by macrophages of
the agr-deficient, unencapsulated derivative (HU-85c) was decreased when compared
with those of the isogenic CP8-capsulated parental strain (HU-85a). By comparison, no
significant differences were found in the bacterial load or the OI from rats challenged
with isogenic Reynolds strains [CP5, CP8, and non-typeable (NT)], indicating that lack of
CP expression alone was not likely responsible for the reduced capacity to cause tissue
damage in HU-85c compared with HU-85a. The production of biofilm was significantly
increased in the isogenic derivative HU-85c. Lack of agr-dependent factors makes S.
aureus less virulent during chronic osteomyelitis and alteration of the agr functionality
seems to permit better adaptation of S. aureus to the chronically infected host.
Keywords: Staphylococcus aureus, adaptation, infection, agr, osteomyelitis, chronic, biofilm, capsular
polysaccharide
INTRODUCTION
Staphylococcus aureus is an ubiquitous opportunistic pathogen that can infect, replicate and persist
in humans thus making this species a worldwide threat to public health. Although S. aureus may
colonize mucosal surfaces of healthy humans with unnoticeable or mild clinical features, it has
the invasive potential to generate diverse life threatening infections. S. aureus is one of the most
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prevalent and difficult-to-eradicate pathogens causing prosthetic
device-associated osteomyelitis (Tong et al., 2015). In addition
to the widespread emergence of methicillin-resistant S. aureus
(MRSA) (Prestinaci et al., 2015), the control of S. aureus
infections is hampered by the evolution of S. aureus with low-
level vancomycin resistance (Howden et al., 2008).
The S. aureus genome carries a vast array of genes coding
for virulence and immune evasion factors. Many of these genes
are conserved in the S. aureus genome and display broad
functionality with considerable redundancy (Tong et al., 2015).
It is believed that initially the ability of S. aureus to regulate
expression of certain virulence factors permits its adaptation
to defined microenvironments in the infected host. Once S.
aureus is well established at the infected tissue, and the infection
becomes refractory to antibiotic treatment, certain regulatory
traits may be fixed by spontaneous mutations occurring during
chronic infection (Tuchscherr et al., 2010), likely due to selection
pressure exerted by a vast number of yet undefined host factors.
These variants are more suitable to evade immune defense
mechanisms than the parental infecting wild type and are able
to generate chronic infection refractory to antibiotic treatment,
not necessarily associated to bacterial antibiotic resistance. A
few phenotypic features such as loss of capsule (types 5 and 8)
expression, loss of SSR repeats in the protein A Xr region and
small colony variant (SCV) emergence have been recognized and
may be considered endpoints in the short term evolution of S.
aureus in the chronically infected host (Proctor et al., 2006; Lattar
et al., 2009; Garofalo et al., 2012; Das et al., 2016). The present
study was designed to investigate the main changes that occurred
in S. aureus in a chronically infected patient persisting over a
period exceeding 1 year.
MATERIALS AND METHODS
Bacterial Strains
S. aureus clinical isolates HU-85a and HU-85c were collected
as the initial isolate and 13 months later, respectively, from
the same infection site (right tibia) of a 20-year-old man with
chronic osteomyelitis (Hospital de Clínicas “General SanMartín,”
Universidad de Buenos Aires, Argentina) (Lattar et al., 2012).
Species was confirmed by a species-specific PCR (Martineau
et al., 1998). S. aureus strain Reynolds (CP5) and its isogenic
derivatives Reynolds CP8 and Reynolds NT (Watts et al., 2005)
were provided by Dr. Jean C. Lee (Division of Infectious Diseases,
Department of Medicine, Brigham and Women’s Hospital and
Harvard Medical School, Boston, MA, USA). All strains were
kept frozen in trypticase soy broth (TSB) with 20% glycerol at
−20◦C and S. aureus was routinely cultured at 37◦C for 24 h
on Columbia agar supplemented with 2% NaCl. To prepare
bacterial inocula S. aureus was cultured on Columbia salt agar
and incubated at 37◦C for 24 h. Bacterial cells were harvested and
suspended to the appropriate density in saline.
The Osteomyelitis Rat Model
Outbred Wistar adult rats weighing 250–350 g were purchased
from local vendors and were kept at the vivarium of the Instituto
de Investigaciones en Microbiología y Parasitología Médica
(IMPaM), Buenos Aires. Animal care was in accordance with the
recommendations of the guidelines set forth by: the 11 report of
the BVAAWF/FRAME/RSPCA/UFAW Joint Working Group on
Refinement (Hawkins et al., 2011). The animal research protocol
utilized in this study was approved by the “Comité Institucional
para el Uso y Cuidado de los Animales de Laboratorio,” through
resolution N◦ 2269 issued on September 17, 2014 by the “Consejo
Directivo de la Facultad de Medicina, Universidad de Buenos
Aires,” Argentina. In order to produce bone infection, rats
were anesthetized with ketamine/xylazine and a 5 µl suspension
containing 1 × 106 CFU of bacteria suspended in fibrin glue
(Tissucol kit 1ml, Baxter Argentina-AG Vienna, Austria) was
injected in the left tibia as describe previously (Lattar et al.,
2014). Groups of rats were sacrificed 14 weeks after intratibial
challenge by exposure to CO2. Both left and right tibias were
removed and the morphometric osteomyelitic index (OI) was
assessed as detailed previously (Lattar et al., 2014). Afterwards
1 cm bone segments involving the infected zone were sectioned,
crushed and homogenized in sterile mortars. Homogenates were
quantitatively cultured overnight on trypticase soy agar (TSA)
and the number of CFU was determined. To validate the
results from the rat model experiments the correlation between
the bacterial load and the OI was tested in the experiments.
Phenotypic expression of α- and β-haemolysin was performed
by evaluating the production of the haemolysis halo in rabbit
and goat blood agar (α- and β-haemolysin, respectively). CP
production was evaluated by colony immunoblot on TSA plates
as described previously (Lee et al., 1990).
Biofilm Formation
Biofilm formation was quantitatively assessed according to a
procedure routinely performed in our laboratory (Dotto et al.,
2017). Briefly, S. aureus suspensions were placed in sterile 96-
well polystyrene microtiter plates. After 24 h incubation at 37◦C,
each culture final optical density at 595 nm (named ODG)
was measured in a microplate reader (Multiskan EX, Thermo
Electron Corp., Waltham, MA, USA). The culture medium was
then removed and plates were washed twice with phosphate
buffered saline (PBS). The biofilms were fixed with 100%
methanol, stained with 0.5% crystal violet and washed with tap
water. After addition of 30% glacial acetic acid biofilm biomasses
were measured by reading the optical density at 595 nm (ODB).
The intensity of crystal violet staining was expressed relative
to the final culture density measured prior to the biofilm assay
(biofilm: ODB)/ODG) and termed “biofilm” in the text for the
sake of clarity. Agr-deficient strain S. aureus SA113 (Iordanescu
and Surdeanu, 1976; Periasamy et al., 2012), which is a robust
biofilm producer, was included in the experiments.
Real Time Quantitative Reverse
Transcription (qRT) PCR
Bacterial RNA was extracted from S. aureus cultures in TSB
harvested at the post-exponential phase, using Trizol Reagent R©
(Invitrogen Life Technologies), according to the manufacturer’s
protocol. RNA was subjected to DNAse treatment using a RQ1
RNAse free DNAse (Promega). cDNA synthesis was performed
with an ImProm-IITM Reverse Transcriptase kit (Promega).
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Quantitative RT-PCR was performed using the SYBR Green PCR
Master Mix (Applied Biosystems) equipment and kits. cDNAwas
subjected to Real time PCR using the following primer pairs:
rnaIII-Fw 5′-TTC ACT GTG TCG ATA ATC CA−3′, rnaIII-Rv
5′-TGA TTT CAA TGG CAC AAG AT-3′ (Vaudaux et al., 2002);
16S-Fw 5′-GATCAGCATGCTACGGTGAA-3′ and 16S-Rv 5′-
ACC TTC CGA TAC GGC TAC CT-3′. Cycling conditions were:
95◦C for 10min followed by 45 cycles of 95◦C for 10 s, 55◦C for
10 s and 72◦C for 15 s, and 1 cycle of 40◦C for 30 s. The 16S gene
was used to normalize data. The number of copies of each sample
transcript was determined with the aid of the 7500 system SDS
software (Applied Biosystems). The (−1CT) value represents the
difference in threshold cycle (Ct) between the target and control
(16S) genes (Livak and Schmittgen, 2001).
Primary Cell Cultures and Cytokine
Detection
Mouse peritoneal macrophages were obtained from BALB/cmice
by peritoneal lavage. Adherent cells were selected after plating
the peritoneal cells in 96-well tissue culture plates. Confluent
cells were stimulated 24 h later with the different bacterial
strains (2–2.5 × 109 CFU/well). Mouse IL-6 and TNFα were
determined quantitatively at 24 h after stimulation by ELISA
using specific antibody pairs (Beckton-Dickinson) as described
previously (Giai et al., 2016).
DNA Extraction, Whole Genome
Sequencing, and Analysis
Genomic DNA was extracted from isolates according to a
standard protocol (Pitcher et al., 1989). DNA libraries were
prepared using Nextera XT (Illumina, San Diego, CA, USA)
and whole genome sequencing was performed using Illumina
HiSeq pair-end sequencing with 500 cycles (Instituto Nacional
de Tecnología Agropecuaria, Castelar, Buenos Aires, Argentina).
FASTQ reads were processed with Trimmomatic (Bolger et al.,
2014) to remove bases from the trailing end that fall below a
PHRED score of 30. Short reads were assembled using SPAdes
v3.10.1 (Bankevich et al., 2012). Contigs less than 500 bp and
30X coverage were discarded. Resulting contigs were ordered
using Mauve 2.4.0 (Darling et al., 2010) and strain MRSA252
as reference. The genome was annotated using Prokka 1.12
(Seemann, 2014). Variant calling was performed using Snippy
v3.2 (Seemann, 2015). The sequences reported in this paper
have been deposited in the NCBI Sequence Read Archive under
Bioproject number PRJNA414566.
Statistical Analysis
Groups of data were statistically compared with the Mann-
Whitney test for non-parametrics. P < 0.05 were considered
statistically significant. Multiple comparisons (three groups of
rats) were performed by the Kruskal-Wallis test for non-
parametrics. The correlation analysis of CFU vs. OI data was
performed with the Spearman test for non-parametrics. Data
from in vitro cytokine and biofilm production was analyzed using
the Student t-test. The Prism GraphPad software (version 5.0)
was used for all statistical analysis.
RESULTS
Isolate Main Features
The characterization of S. aureus isolates HU-85a and HU-
85c revealed that both were MSSA, ST188, CC1, spa type t189
and agr type I, suggesting that these longitudinally collected
isolates shared a recent common ancestor at the infection
site. Since HU-85a was the initial isolate and HU-85c was
collected 13 months later from the same infection site, isolate
HU-85a is considered to be more reflective of the “parent”
isolate. Phenotypic analysis revealed that HU-85c had lost not
only the capacity to express capsular polysaccharide 8 (CP8)
but also α- and β-haemolysin, compared with HU-85a. These
phenotypic features were stable since HU-85c did not regain CP8
or haemolysin expression upon six passages on TSA or blood
agar.
Agr Functionality
To test whether HU-85c was an agr-deficient derivative,
the expression of RNAIII from the agr locus was assessed
by qRT-PCR. The results showed that the relative level of
RNAIII expression was significantly decreased in HU-85c when
compared with HU-85a (Figure 1).
Sequence Analysis
Comparative sequence analysis of HU-85a and HU-85c revealed
two insertions that result in frameshifts in genes coding
proteins: one in the known virulence gene regulator agrC
and the other in the tgt gene encoding Queuine tRNA-
ribosyltransferase, which intervenes in tRNA modification. The
lesion in the agr locus consisted of a C insertion in position
471 of agrC resulting in a truncated product. In addition,
there were a few other mutations, which are described in
Table 1.
FIGURE 1 | Real Time PCR of agr transcripts from strains HU-85a and
HU-85c. Strain Newman was used as reference. Changes in gene expression
are shown as normalized mean fold change −1Ct ± SEM. Data were
normalized to 16S expression. The data represent the mean of duplicate
measurements from 3 independent experiments.
Frontiers in Cellular and Infection Microbiology | www.frontiersin.org 3 February 2018 | Volume 8 | Article 18
Suligoy et al. S. aureus Adaptation during Infection
TABLE 1 | Mutations detected by comparative sequence analysis of isolate HU-85a and its isogenic isolate HU-85c.
LOCUS_TAG Gene Product Type Effect Function
CR496_00168 ? Hypothetical protein del Disruptive inframe deletion Unknown
CR496_00524 sdrD Serine-aspartate repeat-containing protein D snp Missense variant Cell adhesion
CR496_00963 ? Hypothetical protein snp Synonymous variant Unknown
CR496_00965 atl Bifunctional autolysin snp Missense variant Hydrolase
CR496_01541 tgt Queuine tRNA-ribosyltransferase ins Frameshift variant tRNA Modification
CR496_01829 pfbA Plasmin and fibronectin-binding protein A snp Synonymous variant Fibronectin binding protein
CR496_01861 mepM Murein DD-endopeptidase MepM snp Missense variant Metal binding protein
CR496_01941 agrC Accessory gene regulator C ins Frameshift variant Virulence regulator
S. aureus Virulence in an Osteomyelitis Rat
Model
The virulence of the two S. aureus isolates was evaluated in
the rat model of osteomyelitis through determination of the
bacterial load and the OI. Groups of rats infected with parent
isolate HU-85a (agr+) were compared with rats infected with the
derivative isolate HU-85c (agr-deficient). The bacterial load in
the rat tibias and the OI of HU-85c by 14 weeks were significantly
lower than those of HU-85a (Figure 2). No unencapsulated or
non-haemolytic colonies were recovered from the bones of rats
infected with HU-85a by 14 weeks after intratibial challenge.
Histopathological analysis revealed that derivative isolate HU-
85c caused less tissue damage when compared with the parental
isolate HU-85a (Figure 3).
Whereas the loss of CP8 expression by S. aureus HU-85c was
due to agrCmutation, the loss of CP is still a trait associated with
chronic osteomyelitis (Lattar et al., 2009). In order to ascertain
the role of CP expression loss in the osteomyelitis rat model,
groups of rats were infected with S. aureus strain Reynolds CP5
and its isogenic CP8 and NT derivatives. The results revealed no
significant differences among groups (Supplementary Figure 1).
Taken together, these results indicate that the sole loss of CP5 (or
CP8) expression by S. aureus may not be solely responsible for
the reduced virulence of S. aureus in the rat osteomyelitis model.
Assessment of biofilm expression revealed that the mutation
in the agrC resulted in a significant increase in biofilm formation
by isolate HU-85c compared with isolate HU-85a (Figure 4).
Reference strain S. aureus SA113, which is an agr-deficient
derivative of S. aureus strain NCTC8325, produced the expected
robust biofilm levels.
Cytokine Production by Macrophages
Long exposure of S. aureus to the infected human bone
microenvironment may select for additional phenotypic changes.
We examined whether the two isolates differed in ability to
induce pro-inflammatory cytokine expression. A significant
reduction in TNF-α and IL-6 induction was observed in
macrophages in primary culture stimulated with HU-85c (agr+,
CP8), compared with cells stimulated with strain HU-85a
(agr-deficient, NT) (Figure 5). These results indicate that the S.
aureus isolate that persisted in the host with chronic osteomyelitis
exhibited a reduction in its capacity to trigger an inflammatory
response.
DISCUSSION
Genomic and phenotypic assessment of isolates HU-85a andHU-
85c obtained 13 months apart from a patient with osteomyelitis
revealed a frameshift mutation in the HU-85c agrC and a
significant reduction in the RNAIII expression by HU-85c
compared with HU-85a, which explain the loss of CP8, α- and
β-hemolysin expression by HU-85c. Our finding agrees with
those of Fischer et al., who showed in a study on S. aureus
isolates from different sources that all non-encapsulated S. aureus
isolated from human infections are agr deficient (Fischer et al.,
2014). However, in S. aureus strains of the USA300 and USA500
backgrounds, which are not closely related to the ST188 strain
studied here, the loss of capsular expression is due to mutations
in the capsular genes rather than in a regulator of capsule (Boyle-
Vavra et al., 2015). The S. aureus genome is capable of adapting to
environmental changes, which can lead to significant phenotypic
diversification among clinical isolates (Goerke and Wolz, 2004,
2010; Takeuchi et al., 2005). A high genetic variability of the agr
locus has been described in S. aureus (Dufour et al., 2002) and
attributed to balancing selection (Thomas et al., 2012). Traber
and coworkers have shown that agr-defective variants arise by
mutation during the course of infection (Traber et al., 2008).
It was also reported that 9% of healthy human subjects are
colonized with agr-defective strains (Shopsin et al., 2008) and
that 22% of S. aureus isolates from chronically infected patients
with atopic dermatitis had an agr mutant-like phenotype (Soong
et al., 2015). In a recent study, it was shown that mutation in
the agr locus occurs at a different rate in S. aureus of dissimilar
clonal types (Recker et al., 2017). From the virulence standpoint,
a mutation of the agr induces not only the lack of CP5(8)
expression but also the lack of expression of secreted virulence
factors (Novick, 2003), which resulted in reduced virulence in
a model of septic arthritis (Blevins et al., 2002). Regulation of
virulence factor expression by the agr system also seems to play
an essential role in the adaptation of S. aureus to persistence at
intracellular niches (Grundmeier et al., 2010). It has been shown
that common single nucleotide polymorphisms that abrogate
production of α-haemolysin and interfere with signaling of the
agr reduced the virulence of contemporary hospital-associated
MRSA and clinical MSSA included in S. aureus CC30. The
authors concluded that loss of RNAIII expression, in addition to
other defined mutations, made S. aureus less virulent to mice and
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provided the bacteria with suitable niche-adaptation (McGavin
et al., 2012). In the present report we describe that loss of agr
expression can occur in chronically infected patients with S.
aureus osteomyelitis. Similarly, the reduction or total loss of agr
functionality has been previously described in S. aureus from the
cystic fibrosis patient lung (Goerke et al., 2000; Kahl et al., 2003).
This association between persistence of S. aureus in the infected
host and loss of agr expression supports the hypothesis that a
non-functional agr may provide an advantage to S. aureus by
defining a phenotype able to better adapt to persistence in the
host.
Long-term persistence in the host leads to changes in the S.
aureus genome. In a study on 1163 S. aureus genomes, Young
and coworkers described one of these genome changes, i.e., the
emergence of variants in protein altering genes responding to
rsp, agr and host-derived antimicrobial peptides (Young et al.,
2017). The authors further suggest that these changes emerge as a
result of disease-associated, short-term, within-the-host selection
pressures. Whereas in our study the factor responsible for S.
aureus HU-85c positive selection is obscure it is interesting
to note that S. aureus evolved from a capsulated into a non-
encapsulated phenotype due tomutation in a regulator. Although
diverse mechanisms account for loss of CP5(8) expression
(Cocchiaro et al., 2006) so far only antibodies to CP5(8) have been
pointed out as responsible for exerting selective pressure that lead
to the emergence of stable NT S. aureus during experimental
infection (Tuchscherr et al., 2008). In any event, it is speculated
that adaptation of S. aureus for persistence at the infection site
is multifactorial, as much as virulence, and that further research
is needed to identify the specific host factors that exert selective
pressure leading to the emergence of bacterial variants better
adapted to persistence.
Amajor strategy displayed by S. aureus to support unfavorable
conditions is to adopt the biofilm lifestyle, which plays a relevant
role in chronic persistent infections, such as prosthetic implant
associated infection (Archer et al., 2011). The importance of
biofilm formation in S. aureus adaptation to the host to cause
severe infection has been strengthened in a recent review article
(Dastgheyb and Otto, 2015). In the present study it is shown
that during infection mutation in the agrC led to significantly
increased biofilm production. It is known that Agr negatively
controls biofilm formation and that agr mutant strains of S.
aureus produce thicker biofilms (Vuong et al., 2000). Since agr
mutants are frequently isolated from biofilm-covered prosthetic
implants, it can be assumed that robust biofilms confer an
advantage to bacteria during chronic infection. Agr mutants,
therefore, likely represent a dead end of infection, because they
lack the capacity to disseminate within the body or establish
infection in other hosts (Periasamy et al., 2012).
The progression of S. aureus osteomyelitis from acute into
chronic may be benefited from evolution within the host from
an aggressive phenotype, perhaps better adapted to cause bone
damage at the start of the infection process into a less aggressive
phenotype better adapted to persistence and responsible for
chronic infection refractory to antibiotic treatment. The role of
the evolutionary change in S. aureus during the progression of
infection from acute into chronic has gained interest over the
FIGURE 2 | CFU/tibia (upper) and OI (middle) from rats infected with strains
HU-85a and HU-85c. Bacterial loads and OI were measured 14 weeks after
intratibial challenge. The sample size was n = 9 (HU-85a) and n = 12
(HU-85c), in both panels. The scattergram bars in the upper and middle
panels represent the medians. The levels of significance are shown on the
charts (Mann-Whitney test). The lower panel shows the correlation of the
CFU/bone counts and the OI of all the rats included in the experiments shown
in the upper and middle panels (experiment quality control).
past few years. Expression of traits that permit adaptation of S.
aureus to the host may initially be due to regulatory mechanisms
but, in the long run, these traits may be fixed by mutation
and may be considered endpoints in microevolution. One of
these endpoints in S. aureus microevolution within the host is
the stable SCV, which emerge during infection (Proctor et al.,
2006; Tuchscherr et al., 2015). In vitro studies with host cells
revealed that SCVs are phenotypes that hold low virulence, but
are particularly adapted to the intracellular environment for
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FIGURE 3 | Hematoxylin-eosin-stained sections of bone after intratibial challenge with 106 CFU of S. aureus HU-85a or HU-85c. The strain obtained earlier in the
study (HU-85a; C,D) induced marked alterations that include bone cortex with irregular border/necrosis and bone marrow substituted by inflammatory infiltrates and
invaded by trabecular structures. The strain obtained later in the study (HU-85c; E,F) induced less pathological changes, including significant inflammatory infiltrate
composed of mononuclear cells and reduction of fat cells while the bone cortex exhibited conserved regular borders. (A,B) are stained sections of control,
unchallenged tibias that exhibit normal bone marrow with fat tissue and cells, and a bone cortex with laminar structure.
FIGURE 4 | Biofilm formation by isolates HU-85a and HU-85c. S. aureus
strain SA113 was included as reference. Each bar represents the arithmetic
media ± SEM from 4 to 6 wells from 3 independent experiments. Biofilm
formation values correspond to the optical density at 595 nm of crystal violet
(ODB) measured relative to the final culture density of the bacterial growth
(ODG) after 24 h incubation. The increase in biofilm formation by isolate
HU-85c compared with HU-85a was significant (Student t-test).
long-term persistence (Tuchscherr et al., 2010). Interestingly, all
SCV known so far are agr deficient thus failing to produce agr-
regulated factors (Fraunholz and Sinha, 2012). Another endpoint
of microevolution within the host is the loss of CP5(8) expression
(Lattar et al., 2009). The loss of short sequence repeats (SSRs) in
the protein A polymorphic region Xr is yet another endpoint,
which results in the reduction of the S. aureus ability to trigger
inflammation. In addition, the loss of SSRs was significantly
higher in S. aureus persisting at the infection site in patients with
chronic osteomyelitis or cystic fibrosis compared with patients
with acute infection (Garofalo et al., 2012). In the present study,
persistence of S. aureus in the bone and decreased ability to cause
tissue damage in a rat model of osteomyelitis was associated
with reduced capacity of S. aureus to cause inflammation, in
this case through decreased triggering of proinflammatory
cytokine release by macrophages. Therefore, the loss of RNAIII
expression due to an agrC mutation and the reduction in
virulence of the resulting variant makes functional impairment
of agr another endpoint in microevolution within the
host.
CONCLUSION
Our study demonstrates that S. aureus was able to adapt to
the bone during chronic infection. Stable agr mutants arising
during human chronic osteomyelitis were less able to trigger
inflammation, and to cause bone damage as ascertained in the
rat model of osteomyelitis. Lack of agr-dependent factors turned
S. aureus less virulent and therefore it is suggested that mutations
that alter the agr functionality seem to permit better adaptation
of S. aureus to infection niche, making the reduction of agr
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FIGURE 5 | Production of TNF-α (upper) and IL-6 (bottom) by adherent
mouse peritoneal macrophages stimulated with S. aureus HU-85a (agr+) or
HU-85 (agr-deficient). Each bar represents cytokine concentrations obtained
in representative experiments performed in triplicate. Comparisons of cytokine
concentrations produced by stimulation with the wild-type compared with
stimulation with the agr-deficient derivative were analyzed using the Student
t-test.
functionality yet another endpoint in S. aureus microevolution
within the chronically infected host.
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